Form D · Pharmaceuticals
Viking Scientific, Inc.
San Marcos, CA · CIK 0001724333
Offering snapshot reported Jul 27, 2021 · SEC filing
- Reported sold
- $100K Offering amount: $400K
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 27, 2021 | Initial | $99,999 | No comparison | Not reported | SEC filing |
| Nov 13, 2020 | Initial | $113,500 | No comparison | 7 | SEC filing |
| Dec 7, 2017 | Initial | $20,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-407952
Source: Form D, filed Jul 27, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Dempsey | Director, Executive |
| Joe De Pinto | Director |
| Paul Fisher | Director, Executive, Promoter |
| Gregory Fisher | Director, Executive |
| Glenn Mattes | Director |
| Frank J. Papatheofanis | Director |
| Jeffrey Patton | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
667 Avenida Cordoba
San Marcos, CA, 92069
San Marcos, CA, 92069